PortfoliosLab logoPortfoliosLab logo
IDNA vs. HELX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IDNA vs. HELX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Franklin Genomic Advancements ETF (HELX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than HELX's -5.49% return.


IDNA

1D
-2.18%
1M
-2.18%
YTD
9.51%
6M
10.53%
1Y
41.74%
3Y*
6.48%
5Y*
-8.26%
10Y*

HELX

1D
-2.11%
1M
2.72%
YTD
-5.49%
6M
-7.61%
1Y
31.41%
3Y*
4.34%
5Y*
-4.32%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IDNA vs. HELX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
9.51%17.26%-0.72%-7.63%-42.28%-3.98%59.18%
HELX
Franklin Genomic Advancements ETF
-5.49%26.34%-5.32%1.14%-37.89%9.80%85.05%

Correlation

The correlation between IDNA and HELX is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.82

Correlation (3Y)
Calculated over the trailing 3-year period

0.81

Correlation (5Y)
Calculated over the trailing 5-year period

0.84

Correlation (All Time)
Calculated using the full available price history since Feb 28, 2020

0.83

The correlation between IDNA and HELX has been stable across timeframes, ranging from 0.81 to 0.84 - a consistent structural relationship.

IDNA vs. HELX - Sectors Allocation Comparison


Sectors
IDNA
HELX

Healthcare

97.8%
96.5%

Industrials

0.4%

-

Basic Materials

-

2.7%

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Real Estate

-

-

Technology

-

0.9%

Utilities

-

-

Healthcare

IDNA
97.8%
HELX
96.5%

Industrials

IDNA
0.4%
HELX

-

Basic Materials

IDNA

-

HELX
2.7%

Communication Services

IDNA

-

HELX

-

Consumer Cyclical

IDNA

-

HELX

-

Consumer Defensive

IDNA

-

HELX

-

Energy

IDNA

-

HELX

-

Financial Services

IDNA

-

HELX

-

Real Estate

IDNA

-

HELX

-

Technology

IDNA

-

HELX
0.9%

Utilities

IDNA

-

HELX

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IDNA vs. HELX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA
IDNA Risk / Return Rank: 5757
Overall Rank
IDNA Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 5050
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4343
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7979
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6464
Martin Ratio Rank

HELX
HELX Risk / Return Rank: 3939
Overall Rank
HELX Sharpe Ratio Rank: 4343
Sharpe Ratio Rank
HELX Sortino Ratio Rank: 4343
Sortino Ratio Rank
HELX Omega Ratio Rank: 3939
Omega Ratio Rank
HELX Calmar Ratio Rank: 3737
Calmar Ratio Rank
HELX Martin Ratio Rank: 3131
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDNA vs. HELX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IDNAHELXDifference

Sharpe ratio

Return per unit of total volatility

1.71

1.51

+0.20

Sortino ratio

Return per unit of downside risk

2.48

2.18

+0.29

Omega ratio

Gain probability vs. loss probability

1.28

1.26

+0.02

Calmar ratio

Return relative to maximum drawdown

4.09

1.83

+2.26

Martin ratio

Return relative to average drawdown

11.79

4.78

+7.01

IDNA vs. HELX - Sharpe Ratio Comparison

The current IDNA Sharpe Ratio is 1.71, which is comparable to the HELX Sharpe Ratio of 1.51. The chart below compares the historical Sharpe Ratios of IDNA and HELX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IDNAHELXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.71

1.51

+0.20

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.29

-0.18

-0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

0.22

-0.12

Drawdowns

IDNA vs. HELX - Drawdown Comparison

The maximum IDNA drawdown since its inception was -68.26%, which is greater than HELX's maximum drawdown of -58.75%. Use the drawdown chart below to compare losses from any high point for IDNA and HELX.


Loading charts...

Drawdown Indicators


IDNAHELXDifference

Max Drawdown

Largest peak-to-trough decline

-68.26%

-58.75%

-9.51%

Max Drawdown (1Y)

Largest decline over 1 year

-10.66%

-18.01%

+7.35%

Max Drawdown (3Y)

Largest decline over 3 years

-29.73%

-29.48%

-0.25%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

-58.75%

-9.51%

Current Drawdown

Current decline from peak

-46.01%

-40.70%

-5.31%

Average Drawdown

Average peak-to-trough decline

-36.24%

-34.31%

-1.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.70%

6.91%

-3.21%

Volatility

IDNA vs. HELX - Volatility Comparison

iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Franklin Genomic Advancements ETF (HELX) have volatilities of 7.24% and 7.00%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IDNAHELXDifference

Volatility (1M)

Calculated over the trailing 1-month period

7.24%

7.00%

+0.24%

Volatility (6M)

Calculated over the trailing 6-month period

18.21%

16.24%

+1.97%

Volatility (1Y)

Calculated over the trailing 1-year period

24.51%

20.89%

+3.62%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.42%

24.13%

+4.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.53%

27.40%

+2.13%

IDNA vs. HELX - Expense Ratio Comparison

IDNA has a 0.47% expense ratio, which is lower than HELX's 0.50% expense ratio.


Dividends

IDNA vs. HELX - Dividend Comparison

IDNA's dividend yield for the trailing twelve months is around 1.08%, more than HELX's 0.42% yield.


PositionTTM2025202420232022202120202019
HELX
Franklin Genomic Advancements ETF
0.42%0.39%0.00%0.00%0.00%0.24%0.12%0.00%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.08%1.18%0.98%1.04%0.54%0.70%0.26%0.80%

Frequently Asked Questions


IDNA and HELX have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.24%) compared to HELX (7.00%). In terms of maximum drawdown, IDNA dropped -68.26% vs HELX's -58.75%.

On 5-year performance, HELX leads with -4.32% vs -8.26% for IDNA. On fees, IDNA is cheaper at 0.47% per year. On volatility, HELX has been the lower-risk option at 7.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, HELX has performed better with a -4.32% return vs -8.26%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for HELX.

IDNA has the higher dividend yield at 1.08%, compared with 0.42% for HELX.

They also come from different issuers: iShares and Franklin Templeton. Their fees differ too: 0.47% for IDNA and 0.50% for HELX.

IDNA currently has the higher Sharpe Ratio (1.71 vs 1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IDNA and HELX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer